| Primary |
| Essential Hypertension |
25.0% |
| Atrial Fibrillation |
12.5% |
| Benign Prostatic Hyperplasia |
12.5% |
| Gastrooesophageal Reflux Disease |
12.5% |
| Hypercholesterolaemia |
12.5% |
| Iron Deficiency |
12.5% |
| Type 2 Diabetes Mellitus |
12.5% |
|
| Vomiting |
33.3% |
| Pemphigus |
16.7% |
| Pleural Effusion |
16.7% |
| Shock |
16.7% |
| Weight Decreased |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
23.7% |
| Hypertension |
14.4% |
| Essential Hypertension |
7.2% |
| Type 2 Diabetes Mellitus |
7.2% |
| Hypercholesterolaemia |
4.1% |
| Rheumatoid Arthritis |
4.1% |
| Thrombosis Prophylaxis |
4.1% |
| Hypertension |
3.1% |
| Benign Prostatic Hyperplasia |
3.1% |
| Gastroenteritis |
3.1% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Her-2 Positive Breast Cancer |
3.1% |
| Iron Deficiency |
3.1% |
| Mineral Supplementation |
3.1% |
| Optic Nerve Disorder |
3.1% |
| Anaemia |
2.1% |
| Bladder Disorder |
2.1% |
| Clostridial Infection |
2.1% |
| Eye Disorder |
2.1% |
| Hepatitis C |
2.1% |
|
| Vomiting |
13.8% |
| Pemphigus |
10.3% |
| Hypotension |
6.9% |
| Overdose |
6.9% |
| Syncope |
6.9% |
| Tubulointerstitial Nephritis |
6.9% |
| Accidental Overdose |
3.4% |
| Drug Abuse |
3.4% |
| Gamma-glutamyltransferase Increased |
3.4% |
| Infarction |
3.4% |
| Leukopenia |
3.4% |
| Nausea |
3.4% |
| Nervous System Disorder |
3.4% |
| Pruritus |
3.4% |
| Sleep Apnoea Syndrome |
3.4% |
| Somnolence |
3.4% |
| Throat Irritation |
3.4% |
| Tonsillitis |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Weight Fluctuation |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.1% |
| Hypertension |
23.7% |
| Rheumatoid Arthritis |
10.2% |
| Pain |
3.7% |
| Prophylaxis |
3.3% |
| Parkinson's Disease |
2.8% |
| Diabetes Mellitus |
2.5% |
| Atrial Fibrillation |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Breast Cancer |
2.2% |
| Type 2 Diabetes Mellitus |
2.1% |
| Coronary Artery Disease |
1.6% |
| Osteoporosis |
1.6% |
| B-cell Lymphoma |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Hypercholesterolaemia |
1.2% |
| Psoriasis |
1.1% |
| Colon Cancer |
1.1% |
| Hyperparathyroidism Secondary |
1.1% |
|
| Vomiting |
11.7% |
| Renal Failure Acute |
10.8% |
| Weight Decreased |
9.2% |
| Wrong Technique In Drug Usage Process |
7.5% |
| Carotid Artery Stenosis |
5.0% |
| Pulmonary Embolism |
5.0% |
| Renal Failure |
4.2% |
| Sepsis |
4.2% |
| Syncope |
4.2% |
| Tachycardia |
4.2% |
| Urinary Tract Infection |
4.2% |
| Death |
3.3% |
| Drug Ineffective |
3.3% |
| Dyspnoea |
3.3% |
| Hypertension |
3.3% |
| Nausea |
3.3% |
| Pneumonia |
3.3% |
| Respiratory Failure |
3.3% |
| Systemic Lupus Erythematosus |
3.3% |
| Visual Impairment |
3.3% |
|
